Ares Management
ARES
$123.70
+5.72%
Ares Management is one of the world's largest alternative asset managers, overseeing $671.3 billion in total assets under management (including $409.9 billion in fee-earning AUM as of June 2026) across four segments: credit strategies ($440.5 billion AUM), private equity ($24.5 billion), real estate/real assets ($151.2 billion), and other alternatives ($55.1 billion), serving a client base that is roughly 80% institutional and 20% high-net-worth across more than 35 offices in over 15 countries. Its identity is anchored in credit — the firm is one of the largest non-bank lenders globally, giving it a distinct competitive position as a scaled, direct-origination platform rather than a traditional long-only manager. The current investor narrative is dominated by private credit anxiety: headlines through 2026 have focused on redemption caps and a $1.4 billion fund liquidation at peer Blue Owl, triggering sector-wide risk-off episodes, while analysts debate whether Ares's credit-heavy mix is a growth engine or a concentration risk. Against that backdrop, the stock has de-rated sharply even as the firm continues to grow AUM and fee-related earnings, leaving investors to weigh structural private credit demand against liquidity and credit-cycle fears.…
ARES
Ares Management
$123.70
Related headlines
Investment Opinion: Should I buy ARES Today?
Rating: Hold. Ares Management offers a compelling long-term growth story in alternative assets, but near-term headwinds from private credit anxiety and the stock's sharp de-rating warrant a cautious stance. The analyst consensus is Buy with an average target of $145.70, implying 29.8% upside, but the low target of $119 suggests limited downside protection.
Supporting Evidence: The forward PE of 15.8x is attractive relative to the trailing PE of 82.5x, and the 5.0% dividend yield provides income. Revenue grew 5.8% YoY in Q2 2026, and free cash flow TTM is $836 million. However, the net margin of 8.2% and debt-to-equity of 3.49x are concerns. The stock trades at a P/B of 8.2x, which is high for the sector.
Risks & Conditions: The biggest risks are a prolonged private credit downturn, rising redemption requests, and high leverage. This Hold would upgrade to Buy if the stock stabilizes above $120 and private credit fears subside, or if forward EPS estimates are met with margin expansion. It would downgrade to Sell if redemptions accelerate or if the stock breaks below the 52-week low of $95.80. The stock appears undervalued relative to its forward earnings potential but overvalued on book value.
Sign up to view all
ARES 12-Month Price Forecast
Ares Management presents a balanced risk-reward profile. The stock's sharp decline has created valuation support, with forward earnings multiples suggesting recovery potential. However, private credit sector risks and the company's high leverage keep us neutral. We would upgrade to bullish if private credit fears subside and earnings growth accelerates, and downgrade to bearish if redemptions increase or credit losses materialize.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ares Management's 12-month outlook, with a consensus price target around $144.80 and implied upside of +17.1% versus the current price.
Average Target
$144.80
0 analysts
Implied Upside
+17.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$119 - $168
Analyst target range
Bulls vs Bears: ARES Investment Factors
The bear case currently has stronger evidence due to the stock's severe underperformance (-32.5% YTD), private credit contagion fears, and high leverage. However, the bull case rests on a deeply discounted forward valuation (15.8x) and unanimous analyst Buy ratings with a $145.70 target. The most important tension is whether Ares's credit-heavy portfolio can withstand the private credit downturn without significant redemptions or credit losses; resolution of this will determine the stock's trajectory.
Bullish
- Analyst consensus strongly bullish: All 20 analysts rate ARES a Buy (mean 1.95) with an average target of $145.70, implying 29.8% upside from $112.27. The low target of $119 still represents 6.0% upside, suggesting the Street sees limited downside.
- Attractive forward valuation: Forward PE of 15.8x on estimated EPS of $9.67 is well below the trailing PE of 82.5x, reflecting expected earnings growth. The PEG ratio is negative due to trailing earnings, but the forward multiple suggests the market is pricing in a sharp recovery.
- Robust AUM and fee-earning growth: Ares manages $671.3 billion in total AUM, including $409.9 billion in fee-earning AUM, with credit strategies comprising $440.5 billion. This scale provides a durable base of management fees and growth potential.
- High dividend yield with growth: The stock offers a 5.0% dividend yield, attractive for income investors, and the payout ratio of 333% based on GAAP earnings is not reflective of cash flow. Free cash flow TTM is $836 million, supporting the dividend.
Bearish
- Severe relative underperformance: ARES has fallen 20.5% over the past year and 32.5% YTD, massively underperforming the S&P 500's 15.5% and 11.9% gains, respectively. Relative strength is -36.0% over 1 year, indicating persistent weakness.
- Private credit contagion fears: Peer Blue Owl's $1.4 billion fund liquidation and redemption caps have sparked sector-wide risk-off episodes, directly impacting ARES due to its credit-heavy mix ($440.5B AUM). This overhang may persist until confidence is restored.
- High leverage and low net margin: Debt-to-equity is 3.49x, high for an asset manager, and net margin is only 8.2% on a trailing basis. Interest expense of $156 million in Q2 2026 consumes a significant portion of operating income.
- Earnings volatility and GAAP losses: GAAP EPS has been erratic, with a loss in Q1 2026 and net income of only $150.6 million in Q2 2026 despite $1.43 billion in revenue. The trailing PE of 82.5x reflects depressed earnings, and the PEG ratio is negative.
ARES Technical Analysis
Beta
1.55
1.55x market volatility
Max Drawdown
-47.4%
Largest decline past year
52-Week Range
$96-$181
Price range past year
Annual Return
-17.6%
Cumulative gain past year
| Period | ARES Return | S&P 500 |
|---|---|---|
| 1m | -0.8% | -1.2% |
| 3m | -2.2% | +3.4% |
| 6m | +7.4% | +7.0% |
| 1y | -17.6% | +14.4% |
| ytd | -25.6% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ARES Fundamental Analysis
Quarterly Revenue
$1.4B
2026-06
Revenue YoY Growth
+5.8%
YoY Comparison
Gross Margin
17.4%
Latest Quarter
Free Cash Flow
$836147000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ARES Overvalued?
PE
82.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 27x~97x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
28.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Ares carries a debt-to-equity ratio of 3.49x, which is elevated for an asset manager and increases sensitivity to interest rate changes. Interest expense was $156 million in Q2 2026, consuming 63% of operating income ($248.6 million). The company's net margin is only 8.2%, and GAAP earnings are volatile, with a net loss in Q1 2026. Revenue concentration in credit strategies ($440.5 billion, 66% of AUM) exposes the firm to credit cycle downturns and redemption pressures.
Market & Competitive Risks: The stock has a beta of 1.55, indicating higher volatility than the market, and has underperformed the S&P 500 by 36% over the past year. Valuation is rich on some metrics: P/B is 8.2x and EV/EBITDA is 28.7x, leaving little room for error. The private credit sector faces regulatory scrutiny and competitive pressures from traditional banks and other alternative managers. Recent news of Blue Owl's redemption caps and fund liquidation has created sector-wide headwinds that could persist.
Worst-Case Scenario: A severe credit downturn leading to significant redemptions and credit losses could drive the stock to its 52-week low of $95.80, representing a 14.7% decline from the current price of $112.27. If the private credit crisis worsens, the stock could test the analyst low target of $119 (which is above current) but historical max drawdown is -47.76%, implying a potential drop to around $58.70 in an extreme scenario. A more realistic bear case target is $95-$100, a 11-15% downside.
FAQ
The key risks include: 1) Private credit contagion, as seen with Blue Owl's redemption caps, which could lead to redemptions at Ares; 2) High leverage with debt-to-equity of 3.49x, which magnifies losses in a downturn; 3) Earnings volatility, with GAAP net income fluctuating and a net loss in Q1 2026; 4) Valuation risk, as the stock trades at a high P/B of 8.2x despite recent declines. Additionally, the stock has a high beta of 1.55, making it more sensitive to market swings. These risks are ranked from most to least severe, with private credit contagion being the most immediate threat.
Our 12-month forecast has a base case (50% probability) of $120-$145, assuming earnings meet estimates and private credit fears ease. The bull case (25%) targets $145-$168 if sentiment improves and growth accelerates. The bear case (25%) sees $95-$119 if redemptions increase and credit losses occur. The most likely scenario is the base case, with the key assumption that Ares avoids major credit events and continues to grow AUM at a mid-single-digit rate. Analyst average target is $145.70, aligning with our base case upper bound.
ARES appears undervalued on forward earnings, with a forward PE of 15.8x compared to a trailing PE of 82.5x, reflecting expected EPS growth to $9.67. However, on book value, the P/B ratio of 8.2x is high, and EV/EBITDA of 28.7x is elevated. The stock's 5.0% dividend yield is attractive relative to the market. The market seems to be pricing in a recovery in earnings, but the high P/B suggests that tangible book value is low. Overall, the stock is fairly valued to slightly undervalued if earnings estimates are met, but overvalued if private credit headwinds persist.
ARES may be a good buy for long-term investors with a tolerance for volatility, given the 29.8% upside to the average analyst target of $145.70 and a forward PE of 15.8x. However, the stock has fallen 32.5% YTD due to private credit fears, and its high debt-to-equity of 3.49x and low net margin of 8.2% are concerns. The 5% dividend yield provides some income, but the payout ratio is high. The biggest downside risk is a further deterioration in private credit, which could push the stock to its 52-week low of $95.80. Therefore, it is a good buy only for those with a long horizon and diversified portfolio.
ARES is more suitable for long-term investment (3-5 years) given its growth trajectory in alternative assets and current valuation discount. The stock's high beta (1.55) and recent volatility make it less ideal for short-term trading. The 5% dividend yield supports a buy-and-hold strategy, but investors should monitor private credit sector health. A minimum holding period of 2-3 years is recommended to ride out cyclical downturns and benefit from earnings growth. Short-term traders could exploit volatility, but timing is difficult.